Study reveals altered protein rhythms linked to metabolic disorders in night shift workers

FHS
May 9, 2024
6:21 pm

Just a few days on a night shift schedule throws off protein rhythms related to blood glucose regulation, energy metabolism and inflammation, processes that can influence the development of chronic metabolic conditions.

Biodexa gains license for polyposis asset as stock more than doubles – Pharmaceutical Technology

Share this article Familial adenomatous polyposis (FAP) can lead to polyps in the colon and/or rectum which can lead to cancer if not removed. Credit:

April 29, 2024

CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE – Biotech Investments

Issuer: CureVac / Key word(s): Patent 19.12.2023 / 15:23 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Decision of

December 20, 2023

RedHill receives additional US funding for opaganib development

The new oral small molecule pill has a shelf life of five years. Credit: LeviaUA / Shutterstock.com. RedHill Biopharma has received additional funds worth $1.7m from the

July 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.